Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.0350 (-0.3%) ($4.9800 - $5.1500) on Fri. Jul. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.29% (three month average) | RSI | 58 | Latest Price | $5.0350(-0.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VIXM(6%) DRIV(4%) BND(3%) BNDX(3%) GLD(3%) | Factors Impacting BCRX price | BCRX will decline at least -3.145% in a week (0% probabilities). XLV(-9%) SPY(-7%) SPLV(-7%) QQQ(-7%) IWF(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.145% (StdDev 6.29%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.1(-1.27%) | 10 Day Moving Average | $5.22(-3.54%) | 20 Day Moving Average | $4.91(2.55%) | To recent high | -9.8% | To recent low | 0.4% | Market Cap | $888m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |